Skip to main content

Table 5 Univariate Analysis of Variancesa of Two Independent Vitamin D Statusesb and Body Mass Indexc on Atherogenic Indices of Plasma

From: Associations between serum vitamin D3, atherogenic indices of plasma and cardiometabolic biomarkers among patients with diabetes in the KERCADR study

 

Vitamin D Deficiency

Vitamin D Insufficiency

Vitamin D Satisfactory

Sig. Vitamin D

Sig. BMI

Sig. Vit DaBMI

 

≤ median BMI

> median BMI

≤ median BMI

> median BMI

≤ median BMI

> median BMI

Male

Atherogenic Index of Plasma

Case

0.54 ± 0.11

0.66 ± 0.08

0.46 ± 0.08

0.56 ± 0.07

0.55 ± 0.08

0.56 ± 0.11

0.596

0.290

0.846

Control

0.45 ± 0.07

0.63 ± 0.06

0.29 ± 0.05

0.59 ± 0.07

0.35 ± 0.06

0.38 ± 0.06

0.025

0.002

0.112

Castelli Risk Index I

Case

4.40 ± 0.46

4.90 ± 0.35

4.12 ± 0.35

4.50 ± 0.30

4.58 ± 0.33

3.95 ± 0.46

0.583

0.787

0.288

Control

4.34 ± 0.29

5.08 ± 0.25

4.10 ± 0.23

4.88 ± 0.31

3.85 ± 0.26

4.16 ± 0.25

0.029

0.007

0.622

Castelli Risk Index II

Case

2.61 ± 0.32

2.79 ± 0.26

2.44 ± 0.25

2.39 ± 0.21

2.58 ± 0.24

2.16 ± 0.32

0.461

0.665

0.584

Control

2.67 ± 0.24

3.13 ± 0.21

2.67 ± 0.19

3.01 ± 0.26

2.36 ± 0.22

2.65 ± 0.21

0.165

0.052

0.923

Atherogenic Coefficient

Case

3.40 ± 0.46

3.90 ± 0.35

3.12 ± 0.35

3.50 ± 0.30

3.58 ± 0.33

2.95 ± 0.46

0.583

0.787

0.288

Control

3.34 ± 0.29

4.10 ± 0.25

3.10 ± 0.23

3.87 ± 0.31

2.85 ± 0.26

3.16 ± 0.25

0.029

0.007

0.622

Female

Atherogenic Index of Plasma

Case

0.58 ± 0.09

0.62 ± 0.09

0.49 ± 0.18

0.42 ± 0.12

0.61 ± 0.10

0.58 ± 0.09

0.441

0.834

0.873

Control

0.30 ± 0.07

0.40 ± 0.07

0.29 ± 0.12

0.36 ± 0.08

0.27 ± 0.09

0.40 ± 0.07

0.948

0.138

0.939

Castelli Risk Index I

Case

4.28 ± 0.47

4.35 ± 0.49

4.05 ± 0.94

4.04 ± 0.61

4.60 ± 0.51

5.04 ± 0.47

0.416

0.735

0.908

Control

3.68 ± 0.26

4.43 ± 0.25

3.60 ± 0.47

4.34 ± 0.32

3.95 ± 0.36

4.41 ± 0.25

0.823

0.019

0.868

Castelli Risk Index II

Case

2.14 ± 0.34

2.41 ± 0.34

2.24 ± 0.65

2.44 ± 0.43

2.52 ± 0.38

3.06 ± 0.34

0.317

0.340

0.908

Control

2.24 ± 0.22

2.75 ± 0.21

2.19 ± 0.40

2.81 ± 0.27

2.58 ± 0.30

2.84 ± 0.21

0.625

0.043

0.800

Atherogenic Coefficient

Case

3.28 ± 0.47

3.35 ± 0.49

3.05 ± 0.94

3.04 ± 0.61

3.60 ± 0.51

4.04 ± 0.47

0.416

0.735

0.908

Control

2.68 ± 0.26

3.43 ± 0.25

2.60 ± 0.47

3.34 ± 0.32

2.95 ± 0.36

3.41 ± 0.25

0.823

0.019

0.868

  1. a Univariate Analysis of Variances analyzed the differences (Mean ± SE) atherogenic indices between serum vitamin D concentrations based on three vitamin D statuses and body mass index based on median for each gender group in case and control groups
  2. b Vitamin D status divided into vitamin D deficiency (serum vitamin D ≤ 20 ng/ml), vitamin D insufficiency (serum vitamin D > 20-30 ng/ml), and vitamin D satisfactory (serum vitamin D > 30 ng/ml)
  3. c Body mass index dichotomized into body mass index ≤25.99 and > 26.00 in male case group and dichotomized into body mass index ≤26.49 and > 26.50 in female case group; and dichotomized into body mass index ≤24.99 and > 25.00 in male control group and dichotomized into body mass index ≤25.99 and > 26.00 in female control group
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us